Abstract
BackgroundOsteoporosis is a worldwide health problem predominantly affecting post-menopausal women. Therapies aimed at increasing bone mass in osteoporetic patients lag behind comparable investigation of therapeutic strategies focusing on the bone resorption process. Sesamin, a major lignan compound found in Sesamun indicum Linn., has a variety of pharmacological effects, though its activity on bone cell function is unclear. Herein we examine the effect of this lignan on osteoblast differentiation and function.MethodCell cytotoxicity and proliferative in hFOB1.19 were examined by MTT and alamar blue assay up to 96 h of treatment. Gene expression of COL1, ALP, BMP-2, Runx2, OC, RANKL and OPG were detected after 24 h of sesamin treatment. ALP activity was measured at day 7, 14 and 21 of cultured. For mineralized assay, ADSCs were cultured in the presence of osteogenic media supplement with or without sesamin for 21 days and then stained with Alizarin Red S. MAPK signaling pathway activation was observed by using western blotting.ResultsSesamin promoted the gene expression of COL1, ALP, OCN, BMP-2 and Runx2 in hFOB1.19. On the other hand, sesamin was able to up-regulate OPG and down-regulate RANKL gene expression. ALP activity also significantly increased after sesamin treatment. Interestingly, sesamin induced formation of mineralized nodules in adipose derived stem cells (ADSCs) as observed by Alizarin Red S staining; this implies that sesamin has anabolic effects both on progenitor and committed cell stages of osteoblasts. Western blotting data showed that sesamin activated phosphorylation of p38 and ERK1/2 in hFOB1.19.ConclusionsThe data suggest that sesamin has the ability to trigger osteoblast differentiation by activation of the p38 and ERK MAPK signaling pathway and possibly indirectly regulate osteoclast development via the expression of OPG and RANKL in osteoblasts. Therefore, sesamin may be a promising phytochemical that could be developed for supplementation of osteoporotic therapy.
Highlights
Osteoporosis is a worldwide health problem predominantly affecting post-menopausal women
Sesamin induced formation of mineralized nodules in adipose derived stem cells (ADSCs) as observed by Alizarin Red S staining; this implies that sesamin has anabolic effects both on progenitor and committed cell stages of osteoblasts
In order to study the anabolic effect of sesamin, we examined mRNA expression of alkaline phosphatase (ALP), bone morphogenetic protein-2 (BMP2), runt related protein 2 (Runx2), type I collagen, and osteocalcin (OC)
Summary
Osteoporosis is a worldwide health problem predominantly affecting post-menopausal women. We examine the effect of this lignan on osteoblast differentiation and function. Osteoporosis, the most common metabolic bone disease, is characterized by low bone density and deterioration of bone micro-architecture [1]. This bone disease results from an imbalance in the bone remodeling process. Both a high rate of bone resorption and insufficiency of bone formation cause patients to develop bone fragility and Osteoblasts, or bone forming cells, are derived from mesenchymal stem cells (MSCs) that are the progenitors of myocytes, chondrocytes and adipocytes [5]. Bone morphogenetic proteins (BMPs), a members of transforming growth factors (TGFs) are known to be essential for regulating osteoblast differentiation, especially via the Smad-dependent signaling pathway [9]. Cross-talk among other signaling pathways may be involved in osteoblastogenesis
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.